A Blister Pack That Looks Like Xanax Is Now Linked to Several Overdoses in Dublin

A blister pack has foil, a printed strip and a tidy row of pills. It looks like a pharmacy handed it over. “The blister packs look very legitimate,” Prof Eamon Keenan, the national clinical lead for addiction services at Ireland’s health service, told RTÉ Radio this week, according to the Irish Medical Times. Inside some of them, he warned, is a new benzodiazepine, a sedative like Xanax or Valium, that is significantly stronger than either and has been linked to several overdoses in Dublin this week.

Packaging is not a promise.

That is the sentence worth taking out of this story. For years the working rule for a lot of people has been that a pill in a pharmacy-style strip is the pharmacy’s pill. Keenan’s warning ends that rule for Dublin, and there is no reason to think the rule was ever safe anywhere pill presses exist.

The drug is unnamed in the report, and it is a one-city warning from one clinician, so be careful what you conclude. We do not know that it is in the United States. What we do have is the direction of the market. Aegis Sciences, a toxicology lab, reports that bromazolam and its relatives made up nearly half of designer-benzodiazepine detections in the second quarter of 2026, down from 68% across 2025 after the federal government scheduled bromazolam in December. Other compounds are taking that share. Designer benzodiazepines are lab-made cousins of prescription sedatives that were never put through drug approval, which means nobody has tested how strong a given pill is, and the person swallowing it finds out first.

Keenan singled out one group: people on opioid replacement therapy, the methadone and buprenorphine that keep many people alive, face an even higher risk, because a sedative on top of an opioid can slow breathing further. That matches the FDA’s long-standing warning that benzodiazepines combined with opioids, alcohol or other drugs are where misuse becomes overdose. For a person in treatment, that is a cruel place to be exposed: they did the hard thing, and the shelf next to their medication just got more dangerous.

If you work with people on medication for opioid use disorder, this week’s move is small: ask every patient, without judgment, where their sedatives are coming from, and find out whether your lab’s panel can detect designer benzodiazepines at all. If you take medication yourself and ever add a sedative, tell your prescriber the true source, because a prescriber can only protect you from what they know about.

The foil was never the medicine.